Humana Q2 adjusted EPS $8.94 beats $8.76 YoY; affirms FY adjusted EPS at least $28.25

HUMANA INC

2023-Q2 EPS reported $17.54 revenue$53,489,000,000

GAAP EPS $7.66 vs $5.48 YoY; adjusted EPS $8.94 vs $8.76; revenue $26.7B (+13% GAAP).
FY 2023 GAAP EPS guidance revised to at least $26.91 from at least $27.88; adjusted EPS affirmed at at least $28.25.
Individual Medicare Advantage membership growth raised by 50k to ~825k (18% growth), above industry.
Benefits expense ratio guidance affirmed at 86.3%-87.3%; CEO cites stabilizing utilization.
Mid-term adjusted EPS target of $37 in 2025 reiterated; recent Medicaid wins in Indiana and Oklahoma.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HUMANA INC reported the quarter ended June 30, 2023 (2Q23) results: revenue $26,747, EPS $7.66.

Period: the quarter ended June 30, 2023 (2Q23)
Revenue: $26,747
EPS: $7.66
Result: reported results

Exact text from the filing

by Humana on February 23, 2023 . 2 Humana Inc. Summary of Results ($ in millions, except per share amounts) 2Q23 (a) 2Q22 (b) YTD 2023 (c) YTD 2022 (d) CONSOLIDATED Revenues $26,747 $23,662 $53,489 $47,632 Revenues - Adjusted (non-GAAP) $25,733 $22,540 $51,385 $45,402 Pretax results $1,262 $1,122 $2,876 $2,342 Pretax results - Adjusted (non-GAAP) $1,470

View on SEC.gov

Browse all earnings releases →

HUMANA INC filing history →

Source: SEC EDGAR

accession 0000049071-23-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.